Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of Palliative Primary Tumor Resection in Colon Cancer Patients With Initially Unresectable Metastases After Induction Chemotherapy: a Prospective, Multicenter, Randomized Controlled Clinical Trial

NCT04416854 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT04416854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04416854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of Palliative Primary Tumor Resection in Colon Cancer Patients With Initially Unresectable Metastases After Induction Chemotherapy: a Prospective, Multicenter, Randomized Controlled Clinical Trial
Lead sponsor
Fudan University
Phase
Phase 3
Overall status
Unknown status
Start date
April 1, 2020
Completion date
December 31, 2025
Enrollment
627 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colon cancer, surgery